STXS Stereotaxis, Inc.
$1.29▼ -0.77%
Healthcare
Other
After hours
$1.36▲ +5.43%
Sep 11, 7:18 PM ET
Volume 473.1K
Avg Volume (10D) 494.9K
Key Metrics & Fundamentals
Market Cap
$129.26M
P/E Ratio
–
Div Yield
–%
52W Range
1.24 - 3.59
% vs 50 MA
-11.41%
% vs 200 MA
-33.23%
RSI-14
36.0
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.81
Free Cash Flow
-$3.74M
Gross Rev
$7.67M
Gross Profit
$4.49M
EBITDA
-$4.16M
COGS
$3.18M
Operating Exp
$9.05M
Operating Income
-$4.57M
EBIT
-$4.57M
Pretax Income
-$4.47M
Net Income
-$4.47M
EPS (Diluted)
-0.05
Price & Volume History
Loading chart…
Recent News
University of Szeged Celebrates Strongest First Month of Robotic Cardiology Program
GlobeNewswire · Sep 3, 2026 11:56 AM
Stereotaxis (STXS) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 18, 2026 10:44 PM
ISRG's US Procedure Growth Slows: Is ACA Headwind a Temporary Concern?
Zacks · Aug 12, 2026 6:33 PM
Stereotaxis, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 12, 2026 12:30 PM
Stereotaxis Q2 Earnings Call Highlights
MarketBeat · Aug 12, 2026 3:04 AM
Stereotaxis Inc. (STXS) Reports Q2 Loss, Lags Revenue Estimates
Zacks · Aug 11, 2026 9:45 PM
Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates
GlobeNewswire · Aug 11, 2026 8:01 PM
Teleflex (TFX) Surpasses Q2 Earnings and Revenue Estimates
Zacks · Aug 6, 2026 12:20 PM
Si-Bone (SIBN) Reports Q2 Loss, Tops Revenue Estimates
Zacks · Aug 3, 2026 10:45 PM
Mobia Medical Appoints Myriam Curet, M.D., to its Board of Directors
GlobeNewswire · Aug 3, 2026 8:05 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See STXS's money flow as a full page
Social Sentiment
No Reddit posts found for STXS.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.